KLK3 and prostate carcinoma: Hugosson et al. found in a study published in NEJM that MRI-directed targeted biopsy is helpful to detect prostate cancer in a low PSA population; although it can miss clinically non-significant diseases which can reduce the risk of overdiagnosis [43].